
Eliyahu Khankin MD , FASN, FAST (He/Him)
Kidney & Pancreas Transplantation
Assistant Professor of Medicine, Harvard Medical School. Director, Clinical Research, Transplant Institute. Director, Transplant Institute Biorepository (T. I. B. R.). Beth Israel Deaconess Medical Center, Boston MA.
Join to View Full Profile
330 Brookline AveBoston, MA 02215
Phone+1 617-667-7000
Fax+1 617-667-3626
Dr. Khankin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eliyahu Khankin is a nephrologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. He received his medical degree from Technion-Israel Inst of Technology Faculty of Medicine and has been in practice 14 years. He also speaks multiple languages, including Russian and Hebrew. He specializes in kidney & pancreas transplantation and is experienced in hypertension, acute renal failure, transplant nephrology, glomerular disease, and dialysis.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2013 - 2014
- Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2011 - 2013
- Technion-Israel Inst of Technology Faculty of MedicineClass of 2002
Certifications & Licensure
- MA State Medical License 2013 - 2026
Awards, Honors, & Recognition
- Fellow of American Society of Transplantation (FAST) American Society of Transplantation, 2019
- Fellow of American Society of Nephrology (FASN) American Society of Nephrology, 2008
Clinical Trials
- Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) Start of enrollment: 2014 Aug 21
- Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry Start of enrollment: 2018 Jan 23
- Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients Start of enrollment: 2019 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsNormalization of wall shear stress as a physiological mechanism for regulating maternal uterine artery expansive remodeling during pregnancy.Eliyahu V. Khankin, Nga Ling Ko, Maurizio Mandalà, S. Ananth Karumanchi, George Osol
FASEB Bioadvances. 2021-09-01 - 2 citationsPeripartum Cardiomyopathy: Is It All in the Timing?Rachel J. Roth Flach, Eliyahu V. Khankin
Hypertension. 2020-01-01 - 33 citationsPlacental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.Ai-ris Y. Collier, Zsuzsanna K. Zsengellér, Elizabeth Pernicone, Saira Salahuddin, Eliyahu V. Khankin
Hypertension in Pregnancy. 2019-07-10
Journal Articles
- Cytomegalovirus Mismatch Still Negatively Affects Patient and Graft Survival in the Era of Routine Prophylactic and Preemptive Therapy: A Paired Kidney AnalysisE V Khankin, F Cardarelli, M Pavlakis, N Leeaphorn, American journal of transplantation
Grant Support
- Physician Scientist AwardNIDDK2014–Present
- Lipid abnormalities in PreeclampsiaNIH/NIDDK2018–2020
Professional Memberships
- Fellow
- Member
- Member
- Member
Other Languages
- Russian, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: